[Federal Register Volume 64, Number 23 (Thursday, February 4, 1999)]
[Notices]
[Page 5678]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-2682]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 29, 1998, Medeva 
Pharmaceuticals CA, Inc., 3501 West Gary Avenue, Santa Ana, California 
92704, made application by letter to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of 
amphetamine (1100), a basic class of controlled substance listed in 
Schedule II.
    The firm plans to synthesize amphetamine to support reintroduction 
of a product.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than (60 days from publication).

    Dated: January 27, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-2682 Filed 2-3-99; 8:45 am]
BILLING CODE 4410-09-M